Zai Lab (ZLAB) Change in Accured Expenses (2020 - 2026)
Zai Lab (ZLAB) posted Change in Accured Expenses of -$17.6 million for Q1 2026, down 253.12% sequentially from $11.5 million in Q4 2025, and up 24.22% YoY from -$14.2 million in Q1 2025.
Analysis
Zai Lab (ZLAB) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Zai Lab has reported Change in Accured Expenses for 7 years, with the latest figure at -$17.6 million in Q1 2026.
- Quarterly Change in Accured Expenses rose 24.22% year-over-year to -$17.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.4 million (up 193.64% YoY) and the FY2025 annual result came in at $4.8 million, up 121.57% from the prior year.
- Change in Accured Expenses slipped to -$17.6 million in Q1 2026 per ZLAB's latest filing, from $11.5 million in the prior quarter.
- Over five years, Change in Accured Expenses peaked at $19.6 million in Q4 2023 and troughed at -$34.2 million in Q1 2024.
- A 5-year average of -$453411.8 and a median of $5.7 million in 2022 frame the typical range for Change in Accured Expenses.
- The sharpest annual moves came in 2022 and 2025: Change in Accured Expenses tumbled 140.71% in 2022, then surged 836.09% in 2025.
- Over 5 years, Change in Accured Expenses stood at $5.8 million in 2022, then jumped by 239.75% to $19.6 million in 2023, then declined by 24.26% to $14.8 million in 2024, then dropped by 22.34% to $11.5 million in 2025, then slumped by 253.12% to -$17.6 million in 2026.
- According to Business Quant data, Change in Accured Expenses over the past three periods registered -$17.6 million, $11.5 million, and $9.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 11.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 55.78 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 212.44 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 61.62 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 68.82 Mn |
| 10 | Zai Lab | 2.94 Bn | 2.23 Bn | 58.15 Mn | 1.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.24 Mn |
| Mar 31, 2026 | -17.64 Mn |
| Dec 31, 2025 | 11.52 Mn |
| Sep 30, 2025 | 9.18 Mn |
| Jun 30, 2025 | 7.33 Mn |
| Mar 31, 2025 | -23.28 Mn |
| Dec 31, 2024 | 14.83 Mn |
| Sep 30, 2024 | -1.25 Mn |
| Jun 30, 2024 | -1.40 Mn |
| Mar 31, 2024 | -34.20 Mn |
| Dec 31, 2023 | 19.58 Mn |
| Sep 30, 2023 | 6.99 Mn |
| Jun 30, 2023 | 8.83 Mn |
| Mar 31, 2023 | -15.59 Mn |
| Dec 31, 2022 | 5.76 Mn |
| Sep 30, 2022 | 4.73 Mn |
| Jun 30, 2022 | 5.74 Mn |
| Mar 31, 2022 | -8.84 Mn |
| Dec 31, 2021 | 9.55 Mn |
| Sep 30, 2021 | -7.49 Mn |